Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brain Gain: Supplements And Nutraceuticals Expand Cognitive Health Science

This article was originally published in The Tan Sheet

Executive Summary

The next generation of substances to slow cognitive decline and perhaps even prevent Alzheimer's disease may take a test run through the dietary supplement and nutraceutical markets
Advertisement

Related Content

Quincy Bioscience receives investment
Quincy Bioscience receives investment
Quincy Bioscience receives investment
Bioenergy Rides Pharma Science Down Rx, Supplement Roads
Nutrient Formulation Improves Verbal Recall In Mild Alzheimer's Patients
Ovos Plots Vivimind Cognitive Supplement Launch, Awaits FDA Reply
Petitioning FDA Is "Hard" But "Right Way" To Sell Former IND As Supplement
Higher DHA Intake Associated With Reduced Risk Of Dementia – JAMA Study
Prevagen
Phosphatidylserine Data Limited To Dementia Mitigation Not Prevention – FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS103198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel